Search

everythinglearnresearchcommunity

for

Search:↓

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

High doses of tryptophan may cause eosinophilic fasciitis.

Certain zinc transporters are essential for healthy skin and managing zinc in the body could help treat skin problems.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Chronic hair diseases can severely affect mental health and self-confidence.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Skin health and diseases are closely linked to metabolic processes.

Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.